Fourth Quarter and Full Year 2024 Earnings February 25, 2025 Forward-Looking Non-GAAP Financial Measures: This presentation also includes certain forward-looking non-GAAP financial measures. We calculate forward-looking non-GAAP financial measures based on internal forecasts that omit certain amounts that would be included in GAAP financial measures. For instance, we exclude the impact of certain charges related to acquisitions, integrations, divestitures and related costs; business transition and related c ...

Exhibit 99.2 Fourth Quarter 2024 Earnings Conference Call February 25, 2025 2 Big Spring Refinery, Big Spring, TX El Dorado Refinery, El Dorado AR Overview • EOP & SOTP efforts • Operations: Another Safe and Reliable Quarter ◦ Successfully completed KSR Turnaround in 4Q'24 ◦ Further progress towards Midstream deconsolidation ◦ Working on additional deconsolidation options ◦ Original cost reductions (ZBB) exceeding $100mm target ◦ On track to achieve upper-end of $80 - $120mm cash flow improvement through en ...

Fourth Quarter and Full-Year 2024 Financial Results Conference Call February 25, 2025 Matt, an XDEMVY® Patient Today's Speakers Bobby Azamian, MD, PhD CEO & Chairman Jeff Farrow Chief Financial & Strategy Officer Aziz Mottiwala Chief Commercial Officer Sesha Neervannan, PhD Chief Operating Officer 2 | © Tarsus Pharmaceuticals | For Investor Purposes Only Forward-Looking Statements This presentation contains forward-looking statements that involve risks and uncertainties. These statements include statements ...

Q4 and FY 2024 Earnings and 2025 Outlook Dustin Semach, President & CEO Roni Johnson, Interim CFO Mark Stone, Investor Relations © 2024 Sealed Air | 1 February 25, 2025 - Conference Call Supplement (Unaudited Results) Safe Harbor and Regulation G Statement Forward-looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by such words as "anticipate," "believe," "plan," "as ...

Q4 & FY 2024 Financial Results & Business Update February 25, 2025 Copyright © 2025 Harmony Biosciences. All rights reserved. Forward-Looking Statements This presentation includes forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in these materials or elsewhere, including statements regarding Harmony Biosciences Holdings, Inc.'s (the "Company") future financial position, preliminary financ ...

2024 Earnings Results + Capital Plan Update February 25, 2025 Information Regarding Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions about the future, involve risks and uncertainties, and are not guarantees. Future results may differ materially from those expressed or implied in any forward-looking statement. These forward-looking statements represen ...

Financial Supplement Q4 2024 Disclaimer This presentation contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management's current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like "aim," "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "forecast," "future," "goal, ...

Investor Presentation February 2025 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, which involve risks, uncertainties, and assumptions. All statements, other than statements of historical fact, including statements regarding Viper's: future performance; business strategy; future operations; estimates and projections of operating income, losses, costs and expenses, returns, cash fl ...

Fourth Quarter Earnings Supplemental February 25, 2025 CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS & NON-GAAP MEASURES This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). All statements other than statements of historical fact are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial position, results of operations, plans, objectives, future p ...

4th Quarter and Full Year 2024 Earnings Presentation February 25, 2025 Safe Harbor Statement Disclosures in this presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, those relating to future financial and operational results, market and broader economic conditions and guidance. Those statements provide our future expectations or forecasts and can be identified by our use of words such as "anticipate," "estim ...